Anticoagulation in Patients With Venous Thromboembolism and Cancer

NCT04618913 · clinicaltrials.gov ↗

ACTIVE_NOT_RECRUITING

Status

1

Enrollment

INDUSTRY

Sponsor class

Conditions

Neoplasms
Embolism

Interventions

DRUG: Apixaban
DRUG: Rivaroxaban
DRUG: Edoxaban
DRUG: Dabigatran
DRUG: VKA
DRUG: LMWH

Sponsor

Pfizer